Anne-Geneviève Marcelin to Prospective Studies
This is a "connection" page, showing publications Anne-Geneviève Marcelin has written about Prospective Studies.
Connection Strength
0.050
-
Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward. Autoimmun Rev. 2021 Feb; 20(2):102729.
Score: 0.009
-
Multicenter comparison of the Cobas 6800 system with the RealStar RT-PCR kit for the detection of SARS-CoV-2. J Clin Virol. 2020 Sep; 130:104573.
Score: 0.009
-
Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19. J Infect. 2021 01; 82(1):159-198.
Score: 0.009
-
Antiretroviral drug reduction in highly experienced HIV-infected patients receiving a multidrug regimen: the ECOVIR study. J Antimicrob Chemother. 2019 09 01; 74(9):2716-2722.
Score: 0.008
-
High Rates of Baseline Drug Resistance and Virologic Failure Among ART-naive HIV-infected Children in Mali. Pediatr Infect Dis J. 2017 Nov; 36(11):e258-e263.
Score: 0.007
-
Qualitative and quantitative HIV antibodies and viral reservoir size characterization in vertically infected children with virological suppression. J Antimicrob Chemother. 2017 04 01; 72(4):1147-1151.
Score: 0.007